LEADER 03382nam 2200757z- 450 001 9910619464903321 005 20231214133700.0 010 $a3-0365-5256-1 035 $a(CKB)5670000000391625 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/93218 035 $a(EXLCZ)995670000000391625 100 $a20202210d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aPersonalized Diagnosis and Therapy for Multiple Sclerosis 210 $cMDPI - Multidisciplinary Digital Publishing Institute$d2022 215 $a1 electronic resource (124 p.) 311 $a3-0365-5255-3 330 $aWe all agree that people with MS need to be cared in a profoundly personalized way. The care of the patient with MS is still based on the presence of relapses, so their successful diagnosis and treatment is fundamental and will condition the therapeutic strategies to follow with the patient. The treatment strategies are a highly controversial topic of debate that is increasingly supported by robust objective biological markers of response and that also increasingly take into account the dynamics and predictors of cognitive impairment along the disease course, which includes the adoption of new trends in the field of machine learning techniques. However, we all know that patient care goes beyond being treated with drugs and we cannot overlook reminding patients of the importance of their lifestyle behaviors that vary according to the MS phenotype, in order to improve their quality of life. Teleconsultation is a new care strategy proved to be feasible and well-received by patients with MS that will undoubtedly become reinforced because it will allow a closer follow-up of the patient without the need for displacement. 606 $aPublic health & preventive medicine$2bicssc 610 $acognition 610 $acognitive impairment 610 $aneuroimaging 610 $alongitudinal 610 $apredictors 610 $amultiple sclerosis 610 $alifestyle behavior 610 $aMS management 610 $aMS phenotype 610 $aquality of life 610 $anatalizumab 610 $aextended interval dose 610 $abiomarker 610 $aCD49d 610 $asVCAM-1 610 $aimmunomonitoring 610 $apersonalized dose 610 $aprognosis 610 $amachine learning 610 $aartificial intelligence 610 $arelapse 610 $apseudo-relapses 610 $amethylprednisolone 610 $atreatment algorithm 610 $amultiple sclerosis treatment 610 $aescalating strategy 610 $ahe-DMT 610 $adiseases modifying therapies 610 $aearly intense therapy 610 $ateleconsultation 610 $ainternet 610 $afeasibility 610 $adigital health 610 $aneuromyelitis optica spectrum disorder 610 $ahealth-related quality of life 610 $amood 615 7$aPublic health & preventive medicine 700 $aRamo-Tello$b Cristina M$4edt$01293873 702 $aRamo-Tello$b Cristina M$4oth 906 $aBOOK 912 $a9910619464903321 996 $aPersonalized Diagnosis and Therapy for Multiple Sclerosis$93022807 997 $aUNINA